Reviva Pharmaceuticals shares fall 19.33% after-hours after announcing a proposed public offering.

Reviva Pharmaceuticals Holdings, Inc. dropped 19.33% in after-hours trading, following the announcement of a proposed public offering. The company intends to offer shares of its common stock and warrants to purchase shares of common stock in a public offering, which can be seen as a bearish signal for the stock.